Anticipating adaptation: tracking the impact of planned and unplanned adaptations during the implementation of a complex population-based genomic screening program.

Adaptations Implementation science Precision medicine

Journal

Translational behavioral medicine
ISSN: 1613-9860
Titre abrégé: Transl Behav Med
Pays: England
ID NLM: 101554668

Informations de publication

Date de publication:
09 Jun 2023
Historique:
pmc-release: 21 04 2024
medline: 12 6 2023
pubmed: 21 4 2023
entrez: 21 04 2023
Statut: ppublish

Résumé

In 2021, the Medical University of South Carolina (MUSC) launched In Our DNA SC. This large-scale initiative will screen 100,000 individuals in South Carolina for three preventable hereditary conditions that impact approximately two million people in the USA but often go undetected. In anticipation of inevitable changes to the delivery of this complex initiative, we developed an approach to track and assess the impact of evaluate adaptations made during the pilot phase of program implementation. We used a modified version of the Framework for Reporting Adaptations and Modification-Enhanced (FRAME) and Adaptations to code adaptations made during the 3-month pilot phase of In Our DNA SC. Adaptations were documented in real-time using a REDCap database. We used segmented linear regression models to independently test three hypotheses about the impact of adaptations on program reach (rate of enrollment in the program, rate of messages viewed) and implementation (rate of samples collected) 7 days pre- and post-adaptation. Effectiveness was assessed using qualitative observations. Ten adaptations occurred during the pilot phase of program implementation. Most adaptations (60%) were designed to increase the number and type of patient contacted (reach). Adaptations were primarily made based on knowledge and experience (40%) or from quality improvement data (30%). Of the three adaptations designed to increase reach, shortening the recruitment message potential patients received significantly increased the average rate of invitations viewed by 7.3% (p = 0.0106). There was no effect of adaptations on implementation (number of DNA samples collected). Qualitative findings support improvement in effectiveness of the intervention after shortening the consent form and short-term positive impact on uptake of the intervention as measured by team member's participation. Our approach to tracking adaptations of In Our DNA SC allowed our team to quantify the utility of modifications, make decisions about pursuing the adaptation, and understand consequences of the change. Streamlining tools for tracking and responding to adaptations can help monitor the incremental impact of interventions to support continued learning and problem solving for complex interventions being delivered in health systems based on real-time data. We tracked adaptations to a large-scale population genetic screening program at the Medical University of South Carolina (MUSC) using the Framework for Reporting Adaptations and Modifications-Enhanced (FRAME). We found adaptations during program roll-out that impacted implementation outcomes. Our approach to tracking adaptations for the program allowed us to quantify the utility of modifications, make decision about pursuing changes, and understand consequences of adaptations.

Autres résumés

Type: plain-language-summary (eng)
We tracked adaptations to a large-scale population genetic screening program at the Medical University of South Carolina (MUSC) using the Framework for Reporting Adaptations and Modifications-Enhanced (FRAME). We found adaptations during program roll-out that impacted implementation outcomes. Our approach to tracking adaptations for the program allowed us to quantify the utility of modifications, make decision about pursuing changes, and understand consequences of adaptations.

Identifiants

pubmed: 37084411
pii: 7135959
doi: 10.1093/tbm/ibad006
pmc: PMC10255754
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-387

Subventions

Organisme : NCI NIH HHS
ID : K00 CA253576
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA210962
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA210963
Pays : United States
Organisme : NIH HHS
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001450
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© Society of Behavioral Medicine 2023. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Med Care. 2017 Jul;55 Suppl 7 Suppl 1:S4-S12
pubmed: 27997456
Contemp Clin Trials Commun. 2018 Jun 12;11:89-94
pubmed: 30003171
Psychiatry Res. 2020 Jan;283:112467
pubmed: 31488332
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
J Med Internet Res. 2017 Mar 30;19(3):e99
pubmed: 28360022
Implement Sci. 2022 Jul 29;17(1):51
pubmed: 35906602
Front Public Health. 2020 May 27;8:194
pubmed: 32528921
Implement Sci. 2019 Jun 6;14(1):58
pubmed: 31171014
Implement Sci. 2021 Jul 13;16(1):71
pubmed: 34256763
Semin Pediatr Surg. 2018 Dec;27(6):375-378
pubmed: 30473042
Implement Sci. 2013 Jun 10;8:65
pubmed: 23758995
Annu Rev Genomics Hum Genet. 2022 Aug 31;23:549-567
pubmed: 35175786
Med Care. 2016 Aug;54(8):772-9
pubmed: 27314262
J Pers Med. 2022 Jul 27;12(8):
pubmed: 36013178
Implement Sci. 2018 Sep 26;13(1):125
pubmed: 30257683
Front Public Health. 2018 Apr 09;6:102
pubmed: 29686983
Pharmacogenomics. 2021 Nov;22(17):1121-1133
pubmed: 34704830
JAMIA Open. 2018 Oct;1(2):202-209
pubmed: 30474076
J Subst Abuse Treat. 2017 Apr;75:22-37
pubmed: 28237051
Neuropsychiatr Dis Treat. 2018 Jan 04;14:165-178
pubmed: 29379289
Behav Ther. 2018 Jul;49(4):525-537
pubmed: 29937255
JAMIA Open. 2022 Oct 28;5(4):ooac092
pubmed: 36325306
Implement Sci. 2020 Jul 20;15(1):56
pubmed: 32690104
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Implement Sci Commun. 2022 Apr 28;3(1):48
pubmed: 35484601
Transl Behav Med. 2017 Dec;7(4):861-872
pubmed: 28620725
J Am Med Inform Assoc. 2016 Apr;23(e1):e162-8
pubmed: 26335985
Clin Trials. 2020 Feb;17(1):30-38
pubmed: 31581836
J Prim Prev. 2013 Jun;34(3):147-61
pubmed: 23605294
Front Genet. 2022 Jul 04;13:865384
pubmed: 35860476

Auteurs

Caitlin G Allen (CG)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Daniel P Judge (DP)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Paul J Nietert (PJ)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Kelly J Hunt (KJ)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Amy Jackson (A)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Sam Gallegos (S)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Katherine R Sterba (KR)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Paula S Ramos (PS)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Cathy L Melvin (CL)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Karen Wager (K)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Ken Catchpole (K)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Marvella Ford (M)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Lori McMahon (L)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Leslie Lenert (L)

Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH